LMAT - Company ID 0001158895
The table below shows LEMAITRE VASCULAR INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $66.55M | $61.05M | $64.23M | $59.87M | $54.82M | $55.85M |
| Cost of revenue | $18.16M | $15.09M | $19.26M | $18.45M | $17.64M | $17.38M |
| Gross profit | $48.40M | $45.95M | $44.97M | $41.42M | $37.18M | $38.47M |
| R&D | $4.06M | $2.97M | $3.54M | $4.09M | $3.66M | $4.28M |
LEMAITRE VASCULAR INC reported annual revenue of $249.60M for fiscal year 2025. That is up 13.5% from $219.86M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $89.15M (FY 2016) to $249.60M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $12.05M | $10.75M | $10.40M | $10.49M | $8.93M | $8.82M |
| Operating income | $17.77M | $20.31M | $16.14M | $12.63M | $13.15M | $14.38M |
| Income tax | $3.99M | $5.21M | $4.29M | $3.23M | $3.41M | $3.68M |
| Net income | $15.68M | $17.36M | $13.78M | $11.01M | $11.14M | $11.83M |
| EPS (diluted) | $0.68 | $0.75 | $0.60 | $0.48 | $0.49 | $0.52 |